Dexamethasone is a type of corticosteroid medication. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
This report contains market size and forecasts of Dexamethasone API in global, including the following market information:
Global Dexamethasone API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dexamethasone API Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Dexamethasone API companies in 2021 (%)
The global Dexamethasone API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
95%-99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dexamethasone API include Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianyao, Xianju Pharma, VTR Bio-Tech, Sun Pharmaceutical, Cipla and Hovione, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dexamethasone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dexamethasone API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Dexamethasone API Market Segment Percentages, by Type, 2021 (%)
95%-99%
90%-95%
Others
Global Dexamethasone API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Dexamethasone API Market Segment Percentages, by Application, 2021 (%)
Injection
Oral
Others
Global Dexamethasone API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Dexamethasone API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dexamethasone API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dexamethasone API revenues share in global market, 2021 (%)
Key companies Dexamethasone API sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Dexamethasone API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianyao
Xianju Pharma
VTR Bio-Tech
Sun Pharmaceutical
Cipla
Hovione
Xinhua Pharma
Steroid SpA
Junyue Pharma
Avik Pharmaceutical
Great Pacific Exports